Polygenic Hyperlipidemias and Coronary Artery Disease Risk

Näytä kaikki kuvailutiedot



Pysyväisosoite

http://hdl.handle.net/10138/314469

Lähdeviite

FinnGen Project , Ripatti , P , Rämö , J T , Mars , N J , Fu , Y , Lin , J , Söderlund , S , Benner , C , Surakka , I , Kiiskinen , T , Havulinna , A S , Palta , P , Freimer , N B , Widén , E , Salomaa , V , Tukiainen , T , Pirinen , M , Palotie , A , Taskinen , M-R & Ripatti , S 2020 , ' Polygenic Hyperlipidemias and Coronary Artery Disease Risk ' , Circulation-Genomic and precision medicine , vol. 13 , no. 2 , pp. 59-65 . https://doi.org/10.1161/CIRCGEN.119.002725

Julkaisun nimi: Polygenic Hyperlipidemias and Coronary Artery Disease Risk
Tekijä: FinnGen Project; Ripatti, Pietari; Rämö, Joel T.; Mars, Nina J.; Fu, Yu; Lin, Jake; Söderlund, Sanni; Benner, Christian; Surakka, Ida; Kiiskinen, Tuomo; Havulinna, Aki S.; Palta, Priit; Freimer, Nelson B.; Widén, Elisabeth; Salomaa, Veikko; Tukiainen, Taru; Pirinen, Matti; Palotie, Aarno; Taskinen, Marja-Riitta; Ripatti, Samuli
Tekijän organisaatio: Institute for Molecular Medicine Finland
Samuli Olli Ripatti / Principal Investigator
Complex Disease Genetics
Helsinki Institute of Life Science HiLIFE
University of Helsinki
Genomics of Neurological and Neuropsychiatric Disorders
Genomics of Sex Differences
Statistical and population genetics
Clinicum
HUS Internal Medicine and Rehabilitation
Research Programs Unit
CAMM - Research Program for Clinical and Molecular Metabolism
Helsinki University Hospital Area
Centre of Excellence in Complex Disease Genetics
Elisabeth Ingrid Maria Widen / Principal Investigator
Genomic Discoveries and Clinical Translation
Department of Mathematics and Statistics
Biostatistics Helsinki
Department of Public Health
Faculty of Medicine
Aarno Palotie / Principal Investigator
HUS Heart and Lung Center
Päiväys: 2020-04
Kieli: eng
Sivumäärä: 7
Kuuluu julkaisusarjaan: Circulation-Genomic and precision medicine
ISSN: 2574-8300
DOI-tunniste: https://doi.org/10.1161/CIRCGEN.119.002725
URI: http://hdl.handle.net/10138/314469
Tiivistelmä: Background: Hyperlipidemia is a highly heritable risk factor for coronary artery disease (CAD). While monogenic familial hypercholesterolemia associates with severely increased CAD risk, it remains less clear to what extent a high polygenic load of a large number of LDL (low-density lipoprotein) cholesterol (LDL-C) or triglyceride (TG)-increasing variants associates with increased CAD risk. Methods: We derived polygenic risk scores (PRSs) with approximate to 6M variants separately for LDL-C and TG with weights from a UK Biobank-based genome-wide association study with approximate to 324K samples. We evaluated the impact of polygenic hypercholesterolemia and hypertriglyceridemia to lipid levels in 27 039 individuals from the National FINRISK Study (FINRISK) cohort and to CAD risk in 135 638 individuals (13 753 CAD cases) from the FinnGen project (FinnGen). Results: In FINRISK, median LDL-C was 3.39 (95% CI, 3.38-3.40) mmol/L, and it ranged from 2.87 (95% CI, 2.82-2.94) to 3.78 (95% CI, 3.71-3.83) mmol/L between the lowest and highest 5% of the LDL-C PRS distribution. Median TG was 1.19 (95% CI, 1.18-1.20) mmol/L, ranging from 0.97 (95% CI, 0.94-1.00) to 1.55 (95% CI, 1.48-1.61) mmol/L with the TG PRS. In FinnGen, comparing the highest 5% of the PRS to the lowest 95%, CAD odds ratio was 1.36 (95% CI, 1.24-1.49) for the LDL-C PRS and 1.31 (95% CI, 1.19-1.43) for the TG PRS. These estimates were only slightly attenuated when adjusting for a CAD PRS (odds ratio, 1.26 [95% CI, 1.16-1.38] for LDL-C and 1.24 [95% CI, 1.13-1.36] for TG PRS). Conclusions: The CAD risk associated with a high polygenic load for lipid-increasing variants was proportional to their impact on lipid levels and partially overlapping with a CAD PRS. In contrast with a PRS for CAD, the lipid PRSs point to known and directly modifiable risk factors providing additional guidance for clinical translation.
Avainsanat: 3111 Biomedicine
1184 Genetics, developmental biology, physiology
3121 General medicine, internal medicine and other clinical medicine
coronary artery disease
humans
hypercholesterolemia
hypertriglyceridemia
risk factors
DENSITY-LIPOPROTEIN CHOLESTEROL
FAMILIAL HYPERCHOLESTEROLEMIA
TRIGLYCERIDES
MUTATIONS
PLASMA
Vertaisarvioitu: Kyllä
Tekijänoikeustiedot: cc_by
Pääsyrajoitteet: openAccess
Rinnakkaistallennettu versio: publishedVersion
Rahoittaja: Helsingin yliopisto
Rahoitusnumero:


Tiedostot

Latausmäärä yhteensä: Ladataan...

Tiedosto(t) Koko Formaatti Näytä
CIRCGEN.119.002725.pdf 427.0KB PDF Avaa tiedosto

Viite kuuluu kokoelmiin:

Näytä kaikki kuvailutiedot